NSAIDs may cause an increased risk of serious cardiovascular and gastrointestinal adverse events, which can be fatal. This risk may increase with duration of use.
- TRADE NAME: Mobic (Boehringer Ingelheim)
- INDICATIONS: Osteoarthritis
- CLASS: COX-2 inhibitor, Non-steroidal anti-inflammatory (NSAID)
- HALF-LIFE: 15–20 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
ACE inhibitors, Adrenergic neurone blockers, Alcohol, Aliskiren, Alpha blockers, Angiotensin II receptor antagonists, Anticoagulants, Antidepressants, Antiplatelet agents, Aspirin, Baclofen, Beta blockers, Bile acid sequestrants, Calcium channel blockers, Cardiac glycosides, Cholestyramine, Clonidine, Clopidogrel, Collagenase, Conivaptan, Corticosteroids, Coumarins, Cyclosporine, Dabigatran, Dasatinib, Desmopressin, Diazoxide, Digoxin, Diuretics, Drotrecogin Alfa, Eplerenone, Erlotinib, Glucosamine, Haloperidol, Heparins, Hydralazine, Ibritumomab, Iloprost, Ketorolac, Lithium, Methotrexate, Methyldopa, Mifamurtide, Minoxidil, Moxonidine, Nitrates, Nitroprusside, NSAIDs, Pemetrexed, Penicillamine, Pentosan, Pentoxifylline, Phenindione, Pralatrexate, Prasugrel, Probenecid, Prostacyclin analogues, Quinolones, Ritonavir, Serotonin/norepinephrine reuptake inhibitors, SSRIs, Sulfonylureas, Tacrolimus, Thrombolytic agents, Tositumomab & Iodine131, Treprostinil, Vancomycin, Venlafaxine, Vitamin K antagonists, Voriconazole, Zidovudine - PREGNANCY: category D from 30 weeks gestation
- See adverse reactions attributed to class:
CARDIOVASCULAR AND GASTROINTESTINAL RISKS
See full prescribing information for complete boxed warning.
Please login to view the rest of this drug profile.
Page last updated 02/04/2025
